The Vietnam atherectomy devices market size reached USD 5.11 Million in 2024. The market is projected to reach USD 7.55 Million by 2033, exhibiting a growth rate (CAGR) of 3.98% during 2025-2033. The market is fueled by the growing adoption of minimally invasive procedures, rising prevalence of cardiovascular diseases and aging population, and technological advancements in laser and solid-state atherectomy systems. Additionally, the increasing focus on healthcare infrastructure development and expanding access to advanced vascular treatments is augmenting the Vietnam atherectomy devices market share.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024 | USD 5.11 Million |
Market Forecast in 2033 | USD 7.55 Million |
Market Growth Rate 2025-2033 | 3.98% |
Increasing Use of Minimally Invasive Procedures
The healthcare industry in Vietnam is undergoing a major change towards minimally invasive surgical procedures, fueled by better patient results, quicker recovery times, and less hospitalization. This change is most easily seen in the space of vascular intervention, where atherectomy procedures are being used more and more compared to conventional surgery methods. Healthcare professionals in Vietnam are adopting these technologies as they provide increased accuracy, lower procedural risk, and better cost-effectiveness than traditional open surgical techniques. Besides this, the increasing trend towards outpatient procedures and the development of ambulatory surgical centers across Vietnam are also driving the use of minimally invasive atherectomy systems. This trend is significant in that it is concurrent with international trends in healthcare towards patient-focused care, where reduced trauma and more rapid recovery are the priorities.
Increased Incidence of Cardiovascular Disorders and Increased Population Aging
Vietnam has an increasing burden of cardiovascular diseases, placing the nation in a wider epidemiological shift from infectious to non-communicable disease. Cardiovascular diseases, specifically peripheral artery disease and coronary artery disease, are increasingly common because of lifestyle factors, urbanization, and demographic changes. Industry reports in 2024 state that in Vietnam, non-communicable diseases (NCDs) such as cardiovascular diseases, chronic respiratory diseases, cancers, and diabetes account for about 80% of all deaths. In addition, the increasing population of older adults, combined with accelerating diabetes, obesity, and smoking rates, produces a growing patient population that demands more advanced vascular intervention. This population fact is compelling healthcare regulators and medical facilities to invest in advanced treatment technologies, such as atherectomy devices, to respond to the increasing clinical demand. Vietnamese government initiatives to develop healthcare infrastructure and universal health coverage programs are making it easier for people to gain access to these sophisticated medical technologies, enabling market growth in both urban and rural areas.
Technological Developments in Laser and Solid-State Atherectomy Devices
The market for atherectomy devices is rapidly changing with technological advancements, with major developments in laser, solid-state systems, and precision-guided interventions revolutionizing the possibility of treatment. These advancements allow healthcare professionals to treat challenging lesions more accurately, with fewer procedural complications, and better long-term results for patients. Current atherectomy systems integrate features including real-time imaging guidance, automated plaque identification, and improved safety features that reduce the risk of vessel perforation and embolization. The innovation of hybrid systems that integrate several therapeutic modalities, such as laser ablation with mechanical cutting, marks a major evolution in the treatment of varied plaque morphologies. The Vietnam atherectomy devices market growth is fueled by the launch of next-generation platforms with better navigability, reduced procedure time, and better clinical outcomes, which makes such technologies more readily available to Vietnamese healthcare providers looking to enhance their vascular intervention capabilities.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country and regional levels for 2025-2033. Our report has categorized the market based on product, application, and end user.
Product Insights:
A detailed breakup and analysis of the market based on the product have also been provided in the report. This includes directional atherectomy devices, orbital atherectomy devices, photo-ablative atherectomy devices, rotational atherectomy devices, and support devices.
Application Insights:
The report has provided a detailed breakup and analysis of the market based on the application. This includes peripheral vascular, cardiovascular, and neurovascular applications.
End User Insights:
A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes hospitals, ambulatory surgery centers, and research laboratories and academic institutes.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include Northern Vietnam, Central Vietnam, and Southern Vietnam.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Million USD |
Scope of the Report |
Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Products Covered | Directional Atherectomy Devices, Orbital Atherectomy Devices, Photo-Ablative Atherectomy Devices, Rotational Atherectomy Devices, Support Devices |
Applications Covered | Peripheral Vascular, Cardiovascular, Neurovascular |
End Users Covered | Hospitals, Ambulatory Surgery Centers, Research Laboratories and Academic Institutes |
Regions Covered | Northern Vietnam, Central Vietnam, Southern Vietnam |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
Key Benefits for Stakeholders: